Center for Psycho-oncology and Palliative Care, Nagoya City University Hospital, Mizuho-cho, Mizuho-ku, Nagoya, Japan.
Department of Psychiatry and Cognitive-Behavioral Medicine, Nagoya City University Graduate School of Medical Sciences, Mizuho-cho, Mizuho-ku, Nagoya, Japan.
Oncologist. 2022 Nov 3;27(11):982-990. doi: 10.1093/oncolo/oyac178.
Although patients with advanced cancer often have poor prognostic awareness, the most effective communication approach for improving prognostic awareness is unclear. In addition, the association between prognostic awareness and preferences for future medical treatment remains unexplored.
We performed a prospective observational study of consecutive patients with advanced or post-operative recurrent non-small cell lung cancer whose disease had progressed after first-line chemotherapy, and their caregivers. We evaluated patterns of clinical discussions about incurability, prognostic awareness, and preference for future medical treatment at baseline and 3 months later.
We obtained 200 valid responses to the questionnaires at baseline and 147 valid responses 3 months later. In addition, 180 caregivers returned valid responses. A total of 54% of patients and 51% of caregivers had accurate awareness at baseline, and 52% of patients had accurate awareness 3 months later. Multiple logistic regression analysis revealed that patients who were informed about incurability in recent and past discussions were significantly more likely to have accurate awareness 3 months later, compared with those who were only informed recently (adjusted odds ratio 5.08; 95% CI, 1.31-19.78; P = .019). Accurate awareness at 3 months was significantly negatively associated with preference for life-prolonging treatment at 3 months after adjusting for covariates (adjusted odds ratio 0.39; 95% CI, 0.17-0.90; P = .028).
Patients with advanced cancer who had both recent and past discussions about incurability with their oncologists have more accurate prognostic awareness. Improving prognostic awareness could reduce the preference for life-prolonging treatment.
尽管晚期癌症患者的预后意识通常较差,但改善预后意识的最有效沟通方法尚不清楚。此外,预后意识与对未来治疗的偏好之间的关联仍未得到探索。
我们对经一线化疗后疾病进展的晚期或术后复发性非小细胞肺癌患者及其照护者进行了前瞻性观察性研究。我们评估了基线时和 3 个月后关于不可治愈性、预后意识和对未来治疗偏好的临床讨论模式。
我们在基线时获得了 200 份有效问卷的回复,在 3 个月后获得了 147 份有效回复。此外,180 名照护者也返回了有效回复。基线时,54%的患者和 51%的照护者具有准确的意识,3 个月后,52%的患者具有准确的意识。多变量逻辑回归分析显示,与仅近期获知不可治愈性的患者相比,在近期和过去的讨论中都获知不可治愈性的患者在 3 个月后更有可能具有准确的意识(调整后的优势比 5.08;95%置信区间,1.31-19.78;P =.019)。在调整了协变量后,3 个月时的准确意识与 3 个月后对延长生命治疗的偏好呈显著负相关(调整后的优势比 0.39;95%置信区间,0.17-0.90;P =.028)。
与仅近期与肿瘤医生讨论不可治愈性的患者相比,与肿瘤医生进行了近期和过去讨论不可治愈性的晚期癌症患者具有更准确的预后意识。提高预后意识可能会降低对延长生命治疗的偏好。